Standardization of Coagulation Factor V Reference Intervals, Prothrombin Time, and Activated Partial Thromboplastin Time in Mice for Use in Factor V Deficiency Pathological Models

被引:4
|
作者
De Pablo-Moreno, Juan A. [1 ]
Liras, Antonio [1 ]
Revuelta, Luis [2 ]
机构
[1] Univ Complutense Madrid, Sch Biol, Dept Genet Physiol & Microbiol, Madrid, Spain
[2] Univ Complutense Madrid, Sch Vet Med, Dept Physiol, Madrid, Spain
关键词
factor V; prothrombin time; activated partial thromboplastin time; mouse; measurement standardization; transfusion; pathological models; factor V deficiency; HEMOPHILIA-A; PLASMA; TRANSFUSION; HEMORRHAGE; EVOLUTION; SELECTION;
D O I
10.3389/fvets.2022.846216
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Factor V together with activated factor X forms the prothrombinase complex, which transforms prothrombin into thrombin. The Mus musculus species is characterized by very high levels of this factor and short clotting times, which hinders accurate measurements. For that reason, a detailed characterization of such parameters is indispensable. A method was designed as part of this study to provide an accurate determination and standardization of factor V levels, prothrombin time and activated partial thromboplastin time in Mus musculus. Those parameters were evaluated in a sample of 66 healthy animals using a semi-automated coagulometer and human diagnostic reagents in an attempt to determine the most appropriate time of day for the extractions. A mouse-based protocol was designed, capable of making corrections to the samples at dilutions of 1:100 for factor V and at of 1:3 for prothrombin time. The goal was to smoothen the calibration curves, which often present with steep slopes and narrow measurement ranges between one calibration point and another. It was found that the most stable period for blood sample extraction was that comprised between the first 6 h of light. No clinical differences were observed between the sexes and reference intervals were established for factor V (95.80% +/- 18.14; 25.21 s +/- 1.34), prothrombin time (104.31% +/- 14.52; 16.85 s +/- 1.32) and activated partial thromboplastin time (32.86 s +/- 3.01). The results obtained are applicable to human or veterinary biomedical research, to transfusional medicine or to pathological models for diseases such as factor V deficiency.
引用
收藏
页数:10
相关论文
共 45 条
  • [21] Assessment of activated partial thromboplastin time and factor IX in subjects attending an anticoagulation clinic
    Legnani, C
    Promenzio, M
    Guazzaloca, G
    Coccheri, S
    Palareti, G
    BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 (06) : 537 - 542
  • [22] PROTHROMBIN TIME, ACTIVATED PARTIAL THROMBOPLASTIN TIME, FIBRINOGENEMIA - A COMPARATIVE-STUDY BETWEEN 2 AUTOMATES OF COAGULATION - KOAGULAB-40A AND ACL-100
    BARBE, D
    BAUDUER, F
    TANGUY, A
    ANNALES DE BIOLOGIE CLINIQUE, 1991, 49 (10) : 507 - 513
  • [23] Effect of reagent batch on activated partial thromboplastin time in canine plasma and use of the ratio system for standardization
    Mischke, R
    BERLINER UND MUNCHENER TIERARZTLICHE WOCHENSCHRIFT, 2002, 115 (5-6): : 225 - 229
  • [24] The interference of factor VIII excess on the detection of lupus anticoagulants by the activated partial thromboplastin time.
    Guermazi, S
    Gorgi, Y
    Ayed, K
    Dellagi, K
    PATHOLOGIE BIOLOGIE, 1997, 45 (01): : 28 - 33
  • [25] Usefulness of the second-derivative curve of activated partial thromboplastin time on the ACL-TOP coagulation analyzer for detecting factor deficiencies
    Tokunaga, Naoki
    Inoue, Chihiro
    Sakata, Toshiyuki
    Kagawa, Kumiko
    Abe, Masahiro
    Takamatsu, Norimichi
    Nakao, Takayuki
    Doi, Toshio
    BLOOD COAGULATION & FIBRINOLYSIS, 2016, 27 (04) : 474 - 476
  • [26] A specific and sensitive activated partial thromboplastin time (APTT)-based factor VIII inhibitor screening assay
    Pinto, Patricia
    Ghosh, Kanjaksha
    Shetty, Shrimati
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2014, 52 (03) : E39 - E41
  • [27] In vitro factor XI activation mechanism according to an optimized model of activated partial thromboplastin time test
    Kramoroff, A
    Nigretto, JM
    BLOOD COAGULATION & FIBRINOLYSIS, 2001, 12 (04) : 289 - 299
  • [28] Anti-Factor Xa and Activated Partial Thromboplastin Time Measurements for Heparin Monitoring in Mechanical Circulatory Support
    Adatya, Sirtaz
    Uriel, Nir
    Yarmohammadi, Hirad
    Holley, Christopher T.
    Feng, Amy
    Roy, Samit S.
    Reding, Mark T.
    John, Ranjit
    Eckman, Peter
    Zantek, Nicole D.
    JACC-HEART FAILURE, 2015, 3 (04) : 314 - 322
  • [29] Influence of factor VIII:C and factor IX activity in plasmas of haemophilic dogs on the activated partial thromboplastin time measured with two commercial reagents
    Mischke, R
    HAEMOPHILIA, 2000, 6 (03) : 135 - 139
  • [30] Anti-Factor Xa Assay Is a Superior Correlate of Heparin Dose Than Activated Partial Thromboplastin Time or Activated Clotting Time in Pediatric Extracorporeal Membrane Oxygenation
    Liveris, Anna
    Bello, Ricardo A.
    Friedmann, Patricia
    Duffy, Melissa A.
    Manwani, Deepa
    Killinger, James S.
    Rodriquez, Daniel
    Weinstein, Samuel
    PEDIATRIC CRITICAL CARE MEDICINE, 2014, 15 (02) : E72 - E79